20-32019117-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001365692.1(CCM2L):āc.641C>Gā(p.Ala214Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000576 in 1,163,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001365692.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCM2L | NM_001365692.1 | c.641C>G | p.Ala214Gly | missense_variant | 5/10 | ENST00000452892.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCM2L | ENST00000452892.3 | c.641C>G | p.Ala214Gly | missense_variant | 5/10 | 2 | NM_001365692.1 | P1 | |
CCM2L | ENST00000262659.12 | c.641C>G | p.Ala214Gly | missense_variant | 5/9 | 1 | |||
ENST00000662576.1 | n.815+9811G>C | intron_variant, non_coding_transcript_variant | |||||||
ENST00000653258.1 | n.704+9811G>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000870 AC: 13AN: 149428Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000533 AC: 54AN: 1013904Hom.: 0 Cov.: 28 AF XY: 0.0000753 AC XY: 36AN XY: 477946
GnomAD4 genome AF: 0.0000869 AC: 13AN: 149534Hom.: 0 Cov.: 33 AF XY: 0.000123 AC XY: 9AN XY: 72994
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 09, 2024 | The c.641C>G (p.A214G) alteration is located in exon 5 (coding exon 5) of the CCM2L gene. This alteration results from a C to G substitution at nucleotide position 641, causing the alanine (A) at amino acid position 214 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at